Literature DB >> 8220656

Snoring and sleep apnoea in men: association with central obesity and hypertension.

R Grunstein1, I Wilcox, T S Yang, Y Gould, J Hedner.   

Abstract

The objective of this study was to examine the relationship between sleep apnoea, measures of obesity and blood pressure. The study was cross-sectional in design, involving 1464 consecutive men undergoing sleep studies at two non-hospital sleep laboratories. Detailed sleep studies, body mass index (BMI), neck, hip and waist circumferences and morning and evening blood pressures were measured in each patient. Twenty-eight per cent of patients were obese (BMI > 30 kg/m2) and 47% were overweight (BMI 26-30 kg/m2). Body fat distribution in these patients was typically central with a mean waist-hip ratio (WHR) for the entire group of 0.99 with over 80% of patients having a WHR more than 0.94. Increasing severity of sleep apnoea measured either by respiratory disturbance index (RDI) or minimum oxygen saturation in sleep (MOS) was associated with increasing central obesity and morning but not evening blood pressure. Normal weight patients (BMI < 25 kg/m2) with sleep apnoea were characterized by increased waist and hip circumferences and increased morning diastolic blood pressure compared to patients without sleep apnoea. The best explanatory variables for sleep apnoea were waist (r2 = 0.156, P < 0.001) and age (r2 = 0.013, P = 0.003) only. Morning but not evening blood pressure was related to sleep apnoea independently of obesity and age. We concluded that patients with sleep apnoea are centrally obese. Waist circumference is a better predictor for sleep apnoea than neck circumference or BMI suggesting that the link between obesity and sleep apnoea cannot be explained solely by neck fat deposition.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8220656

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  69 in total

Review 1.  "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease.

Authors:  I Wilcox; S G McNamara; F L Collins; R R Grunstein; C E Sullivan
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 2.  Sleep apnoea and hypertension: proof at last?

Authors:  J R Stradling; J C Pepperell; R J Davies
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 3.  Cardiovascular consequences of obese and nonobese obstructive sleep apnea.

Authors:  Kannan Ramar; Sean M Caples
Journal:  Med Clin North Am       Date:  2010-05       Impact factor: 5.456

Review 4.  Neurobiology and neuropathophysiology of obstructive sleep apnea.

Authors:  Yanpeng Li; Sigrid C Veasey
Journal:  Neuromolecular Med       Date:  2011-12-15       Impact factor: 3.843

Review 5.  Treatment options for sleep apnoea.

Authors:  R R Grunstein; J Hedner; L Grote
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  Sleep and hypertension.

Authors:  David A Calhoun; Susan M Harding
Journal:  Chest       Date:  2010-08       Impact factor: 9.410

Review 7.  Obstructive sleep apnea and hypertension.

Authors:  David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

Review 8.  Sleep . 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension.

Authors:  G V Robinson; J R Stradling; R J O Davies
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

9.  Obstructive sleep apnea during rapid eye movement sleep, daytime sleepiness, and quality of life in older men in Osteoporotic Fractures in Men (MrOS) Sleep Study.

Authors:  Akram Khan; Stephanie L Harrison; Eric J Kezirian; Sonia Ancoli-Israel; Daniel O'Hearn; Eric Orwoll; Susan Redline; Kristine Ensrud; Katie L Stone
Journal:  J Clin Sleep Med       Date:  2013-03-15       Impact factor: 4.062

10.  Evaluation of sleep apnea in a sample of black patients.

Authors:  Girardin Jean-Louis; Hans von Gizycki; Ferdinand Zizi; Amita Dharawat; Jason M Lazar; Clinton D Brown
Journal:  J Clin Sleep Med       Date:  2008-10-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.